Determinants of Medicare All-Cause Costs Among Elderly Patients with Renal Cell Carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is the third most common genitourinary cancer and the most common primary renal neoplasm. Estimates of the economic burden of RCC in the United States range from approximately $400 million (in year 2000 dollars) to $4.4 billion (in year 2005 dollars). Actual co...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollenbeak, Christopher S., Nikkel, Lucas E., Schaefer, Eric W., Alemao, Evo, Ghahramani, Nasrollah, Raman, Jay D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350946/
https://www.ncbi.nlm.nih.gov/pubmed/21942302
http://dx.doi.org/10.18553/jmcp.2011.17.8.610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350946/
https://www.ncbi.nlm.nih.gov/pubmed/21942302
http://dx.doi.org/10.18553/jmcp.2011.17.8.610

Ejemplares similares